Skip to main content Skip to main navigation menu Skip to site footer

Diabetes

38 Items

All Items

Circulating long noncoding RNAs H19 and GAS5 are associated with type 2 diabetes but not with diabetic retinopathy: A preliminary study

Manal S. Fawzy, Ahmed A. Abdelghany , Eman A. Toraih

365-371
Making sense of subclinical cardiac alterations in patients with diabetes

Manan Pareek, Michael Hecht Olsen

312-314
Predictors of early cardiac changes in patients with type 1 diabetes mellitus: An echocardiography-based study

David Šuran, Vojko Kanič, Franjo Naji, Igor Krajnc, Miro Čokolič, Eva Zemljič, Andreja Sinkovič

384-391
Effects of TCF7L2 rs7903146 variant on metformin response in patients with type 2 diabetes

Tanja Dujic, Tamer Bego, Maja Malenica, Zelija Velija-Asimi, Emma Ahlqvist, Leif Groop, Ewan R. Pearson, Adlija Causevic, Sabina Semiz

368-374
Association of serum chemerin and inflammatory factors with type 2 diabetes macroangiopathy and waist-to-stature ratio

Mengxue Yang, Xue Zhou, Jie Xu, Bo Yang, Jie Yu, Qihai Gong, Xuan Zhang, Xiaohua Sun, Qun Zhang, Jinying Xia, Jianhui Li

328-335
Vascular endothelial growth factor (VEGF)-related polymorphisms rs10738760 and rs6921438 are not risk factors for proliferative diabetic retinopathy (PDR) in patients with type 2 diabetes mellitus (T2DM)

Jana Sajovic, Ines Cilenšek, Sara Mankoč, Špela Tajnšek, Tanja Kunej, Daniel Petrovič, Mojca Globočnik Petrovič

94-100
Histological and biochemical effects of Cinnamomum cassia nanoparticles in kidneys of diabetic Sprague-Dawley rats

Koffi Kouame, Aniekan Imo Peter, Edidiong Nnamso Akang, Roshila Moodley, Edwin Coleridge Naidu, Onyemaechi Okpara Azu

138-145
Effect of Biphasic Insulin Aspart 30 Combined with Metformin on Glycaemic Control in Obese People with Type 2 Diabetes

Belma Aščić - Buturović

335-338
Serum C-Reactive Protein Concentration and Measures of Adiposity in Patients With Type 2 Diabetes Mellitus

Asija Začiragić, Jasminko Huskić, Almira Hadžović-Džuvo, Amina Valjevac, Nesina Avdagić, Nedžad Mulabegović

322-327
Role of α-Lipoic Acid in Diabetic Polyneuropathy Treatment

Azra Bureković, Mirsada Terzić, Salem Alajbegović, Zoran Vukojević, Nedžad Hadžić

341-345
Effects of Basal Insulin Analog and Metformin on Glycaemia Control and Weight as Risk Factors for Endothelial Dysfunction

Belma Aščić – Buturović, Mirsad Kacila

309-312
The Statins in Prevention of Coronary Heart Diseases in Type 2 Diabetics

Bećir Heljić, Zelija Velija-Ašimi, Mehmed Kulić

71-76
Effects of Aggressive Approach to the Multiple Risk Factors for Diabetic Nephropathy on Proteinuria Reduction in Diabetes Type 2 Patients

Belma Aščić – Buturović, Mirsad Kacila, Mehmed Kulić

44-48
Metabolic Control of Type 1 Diabetes in Children Treated with Insulin Pump Therapy

Sniježana Hasanbegović, Edo Hasanbegović

120-124
Friedreich Ataxia (Fa) Associated with Diabetes Mellitus Type 1 and Hyperthrophic Cardiomyopathy

Zoran Gucev, Velibor Tasic, Aleksandra Jancevska, Nada Popjordanova, Svetlana Koceva, Marija Kuturec, Vesna Sabolic

107-110
Evaluation of Risk Markers Fluctuation During an Initial Therapy with Rosiglitazon in Patients Suffering from Metabolic Syndrome

Amra Macić-Džanković, Fuad Džanković, Belma Pojskić, Zelija Velija- Ašimi

320-328
Relevance of Uric Acid in Progression of Type 2 Diabetes Mellitus

Adlija Čaušević, Sabina Semiz, Amra Macić-Džanković, Bakira Cico, Tanja Dujić, Maja Malenica, Tamer Bego

54-59
Chromogranin A Detection in Saliva of Type 2 Diabetes Patients

Martine Soell, Ahmed Feki, Matthias Hannig, Hidehiko Sano, Michel Pinget, Denis Selimović

2-6
The Automatic Regulation of the Basal Dose on the Insulin Pump for the Treatment of Patients that have Diabetes Type 1

Sifet Mehanović, Midhat Mujić

100-106
Ultrasound Measurement of Peripheral Endothelial Dysfunction in Type 2 Diabetic Patients: Correlation with Risk Factors

Marijan Bosevski, Ljubica Georgievska-Ismail

84-88

1-20 of 38 Next